SNSE

Conviction 42HealthcareScan · Mon, Jul 20, 2026

SNSE$13.85+6.54%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 66.42K

Mar 17Apr 2Apr 22May 8May 28Jun 15

Sensei Biotherapeutics, Inc. Common StockPHARMACEUTICAL PREPARATIONSwww.senseibio.com ↗

Price13.85

Change+6.54%

Gap+17.00%

Rel volume4.67×

Avg volume55.97K

Avg $ vol866.23K

SMA 2015.96

SMA 5023.03

SMA 20016.24

Price vs 50-39.87%

Price vs 200-14.73%

MA stackmixed

50/200 cross—

Supertrenddown · 19.72

RSI (14)39

MACD hist-0.03

MACD crossbear · 5d

Stoch %K / %D29 / 16

ADX (14)27

+DI / −DI18 / 24

RSI divergence—

MACD divergence—

ATR %+19.44%

ADR %16.26%

52w high35.07

52w low0.0000

From 52w high-60.51%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width69.19%

%B0.31

Donchian pos26.22%

Donchian high22.49

Donchian low10.78

AVWAP (52w high)27.17

vs AVWAP high-49.02%

AVWAP (52w low)22.60

vs AVWAP low-38.70%

OBV trendFlat

Chaikin MF (20)-0.42

Today vs 20d4.67×

Avg vol (14d)66.42K

Avg vol (20d)55.97K

Avg $ vol (20d)866.23K

Market cap17.45M

RS 3m (vs SPY)-66.50%

RS 6m (vs SPY)+44.36%

RS line new highNo

Trend template3/8

Technical rank40.5

1 week+6.54%

1 month-30.12%

3 months-53.68%

6 months+53.89%

1 year+4028.17%

YTD+43.60%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeXNAS

Shares out1.34M

Employees29

ListedThu, Feb 4, 2021

Free float775.92K

Float %57.9%

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank40.5 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance33.11

Support13.13

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in SNSE

All disclosures →

No recent disclosed trades by Congress in SNSE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNSE · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Peyer James 10% owner · Common Stock · 2026-06-01	Sell	476	$10K	2026-06-01	2026-06-01
Cambrian BioPharma Inc 10% owner · Common Stock · 2026-06-01	Sell	24.52K	$490K	2026-06-01	2026-06-01
Cambrian BioPharma Inc 10% owner · Common Stock · 2026-06-01	Sell	476	$10K	2026-06-01	2026-06-01
Peyer James 10% owner · Common Stock · 2026-06-01	Sell	24.52K	$490K	2026-06-01	2026-06-01
MILLENNIUM GROUP MANAGEMENT LLC 10% owner · Common Stock · 2026-04-07	Buy	1.11K	$37K	2026-04-07	2026-05-15
ICS OPPORTUNITIES II LLC 10% owner · Common Stock · 2026-04-07	Buy	1.11K	$37K	2026-04-07	2026-05-15
ICS OPPORTUNITIES II LLC 10% owner · Common Stock · 2026-04-07	Sell	2.12K	$61K	2026-04-07	2026-05-15
ENGLANDER ISRAEL A 10% owner · Common Stock · 2026-04-07	Sell	300	$10K	2026-04-07	2026-05-15
ICS OPPORTUNITIES II LLC 10% owner · Common Stock · 2026-04-07	Sell	4.42K	$139K	2026-04-07	2026-05-15
MILLENNIUM MANAGEMENT LLC 10% owner · Common Stock · 2026-04-07	Sell	2.12K	$61K	2026-04-07	2026-05-15

SEC filings

EDGAR filings in SNSE · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.